Perspective: 2025 Vol: 17 Issue: 1
The Potential of Natural Extracts against Multi-Drug Resistant Pathogens
Madar Lebbar*
Department of Pharmacy, University of Toronto, Ontario, Canada
*Corresponding Author:
Received: 28-Oct-2024, Manuscript No. JOCPR-24-151302; Editor assigned: 31-Oct-2024, PreQC No.
JOCPR-24-151302 (PQ); Reviewed: 14-Nov-2024, QC No. JOCPR-24-151302; Revised: 15-Jan-2025, Manuscript
No. JOCPR-24-151302 (R); Published: 22-Jan-2025, DOI:10.37532/0975-7384.2025.17(1).243.
Citation: Lebbar M. 2025. The Potential of Natural Extracts against Multi-Drug Resistant Pathogens. J. Chem Pharm.
Res., 17:243.
Abstract
Introduction
Global health is seriously threatened by the emergence of Multi-Drug Resistant (MDR) bacteria, which make many traditional antibiotics useless. As a result, scientists are looking more and more at natural extracts from fungus, plants, and other species as other sources of antimicrobial drugs. Because of their varied chemical compositions and modes of action, natural extracts which have been utilized in traditional medicine for centuries offer a viable approach to fighting MDR infections. The possibility of natural extracts as a workable remedy for the escalating problem of antibiotic resistance is covered in this article.
The capacity of pathogenic microbes to resist the effects of many antimicrobial medications that were once successful against them is known as multi-drug resistance. Numerous things, such as the overuse and abuse of antibiotics, insufficient infection control procedures, and the infections' inherent evolutionary processes, might contribute to this resistance. Treatment for infections brought on by MDR bacteria, fungi, and viruses is therefore getting harder, which results in longer hospital stays, more medical expenses, and higher death rates. Methicillin-Resistant Staphylococcus aureus (MRSA), Vancomycin-Resistant Enterococcus (VRE), and certain strains of Escherichia coli and Klebsiella pneumoniae are common examples of Multidrug-resistant bacteria (MDR) strains.
Through processes including the acquisition of resistance genes, the enzymatic breakdown of antibiotics, and modifications in cell permeability that block drug entrance, some species have evolved resistance. As the prevalence of MDR pathogens continues to rise, the urgent need for new therapeutic strategies becomes increasingly apparent.
Description
.Natural extracts include a wide range of bioactive substances with antibacterial qualities. These substances can include phenolics, terpenoids, alkaloids, flavonoids, and essential oils, all of which may enhance their ability to combat infections. Comparing these molecules to traditional antibiotics, their variety enables a wide range of interactions with microbial cells, offering various sites for action and lowering the risk of resistance development.
The historical basis for the antibacterial activity of natural extracts comes from their centuries-long usage in traditional medicine across many civilizations. Numerous studies that show the antiviral, antifungal, and antibacterial properties of numerous natural extracts against MDR pathogens have launched contemporary scientific study to support these traditional usages.
Natural extracts have antibacterial properties through a variety of intricate methods. The breakdown of bacterial cell membranes is one typical method of action. Increased permeability and ultimately cell lysis can result from substances like essential oils and certain phenolic chemicals integrating into the lipid bilayer of microbial membranes. Because it may circumvent some resistance mechanisms that organisms may have evolved against traditional antibiotics, this method is very beneficial. Inhibition of vital enzymatic pathways in pathogens is another approach. For example, it has been demonstrated that alkaloids and flavonoids disrupt important metabolic functions such energy generation, protein synthesis, and DNA replication. Natural extracts can successfully prevent the development and spread of resistant germs by focusing on these vital processes.
Additionally, natural extracts can alter the immune system, improving the host's defenses against infections. Certain substances have anti-inflammatory qualities that can assist lessen tissue damage during infection, while others promote the formation of immune cells. A thorough method of treating infections brought on by MDR organisms is offered by this dual action, which targets pathogens directly while strengthening host defenses.
Numerous research has demonstrated that several natural extracts have antibacterial properties. Examples of plant extracts that have demonstrated strong antibacterial action against MRSA strains and other MDR infections include garlic (Allium sativum), ginger (Zingiber officinale), and turmeric (Curcuma longa). Key players in these plants' antimicrobial properties have been found to be their active ingredients, such as curcumin in turmeric and allicin in garlic. Apart from plant extracts, certain fungi have also shown encouraging antibacterial qualities. Extracts from the fungus Ganoderma lucidum, for example, have demonstrated inhibitory actions against a variety of harmful bacteria and fungi. It is believed that this mushroom's polysaccharides and triterpenes are essential to its antibacterial properties.
Conclusion
A major public health concern is the emergence of multidrug-resistant bacteria, which calls for creative ways to infection control. A prospective substitute or supplement to conventional antibiotics is natural extracts from plants, fungus, and marine creatures, which have a long history of usage in traditional medicine and a variety of modes of action. Even though there are still issues with formulation, distribution, and regulations, more research and development in this area may lead to new treatment alternatives to counteract the rising problem of antibiotic resistance.